Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $51.9292 (-0.39%) ($51.5967 - $52.2879) on Fri. Sep. 11, 2015. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.64% (three month average) | RSI | 33 | Latest Price | $51.9292(-0.39%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -0.7% a day on average for past five trading days. | Weekly Trend | ABBV declines -3.1% a week on average for past two weeks. | Market Behavior | Normal for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(61%) IBB(47%) VYM(47%) IVE(46%) IWD(45%) | Factors Impacting ABBV price | ABBV will decline at least -0.82% in a week (0% probabilities). VIXM(-20%) TLT(-14%) UUP(-9%) IGOV(-3%) GLD(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.82% (StdDev 1.64%) | Hourly BBV | 0 () | Intraday Trend | -0.5% | | | |
|
1 - 5 Day Possible Target | $43.21(-16.79%) | Resistance Level | $55.32 | 5 Day Moving Average | $52.24(-0.59%) | 10 Day Moving Average | $53.13(-2.26%) | 20 Day Moving Average | $55.32(-6.13%) | To recent high | -16.7% | To recent low | 0.2% | Market Cap | $91.618b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |